Malignant Melanoma Archive - Seite 13 von 19 - IOZK

Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells

2008-06-01/in International Publications, Malignant Melanoma /von 2008-06-01 / J. Immunother. 2008 Jun;31(5):458-65

Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency

2008-05-15/in International Publications, Malignant Melanoma /von 2008-05-15 / Gene Ther. 2008 Oct;15(19):1321-9

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy

2008-05-01/in International Publications, Malignant Melanoma /von 2008-05-01 / J. Immunother. 2008 May;31(4):345-58

Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma

2008-05-01/in International Publications, Malignant Melanoma /von 2008-05-01 / J. Immunother. 2008 May;31(4):402-12

Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma

2008-04-24/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2008-04-24 / Vaccine 2008 Jun;26(27-28):3540-9

Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells

2008-04-01/in International Publications, Malignant Melanoma /von 2008-04-01 / Cancer Biother. Radiopharm. 2008 Apr;23(2):214-21

Cancer vaccines for established cancer: how to make them better?

2008-04-01/in International Publications, Malignant Melanoma /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:242-55

Strategies and challenges in eliciting immunity to melanoma

2008-04-01/in International Publications, Malignant Melanoma /von 2008-04-01 / Immunol. Rev. 2008 Apr;222:28-42

Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity

2008-02-26/in International Publications, Malignant Melanoma /von 2008-02-26 / J. Cancer Res. Clin. Oncol. 2008 Sep;134(9):987-94

Dendritic cell vaccines in melanoma: from promise to proof?

2008-02-08/in Dendritic Cells, International Publications, Malignant Melanoma /von 2008-02-08 / Crit. Rev. Oncol. Hematol. 2008 May;66(2):118-34